Gryphus Diagnostics, L.L.C.

Click Here To EMAIL INQUIRY
Contact: Stephen Johnson, Ph.D.
Web: http://www.gryphus.com
E-Mail:
Address: 2280 Sutherland Avenue, Suite 101, Knoxville, Tennessee 37919-2326, USA
Phone: +1-(865)-251-0101, 800- 924-419 | Fax: +1-(865)-251-0108 | Map/Directions >>

Profile: Gryphus Diagnostics, LLC specializes in development and manufacture of rapid detection systems. Our products is BVblue® rapid tests for bacterial vaginosis. Our BVblue® is for use in the clinical evaluation of elevated vaginal fluid sialidase activity in women suspected of having bacterial vaginosis. It is used to find the bacterial pathogens like gardnerella vaginalis, bacteroides spp, prevotella spp and mobiluncus spp.

The company was founded in 1998. TSE:CUR (SEC Filings)

FDA Registration Number: 3006546675

6 Products/Services (Click for related suppliers)

• Bacterial Sialidase Vaginal Test (FDA Code: MXB / 866.2660)

A microorganism differentiation and identification device is a device intended for medical purposes that consists of one or more components, such as differential culture media, biochemical reagents, and paper discs or paper strips impregnated with test reagents, that are usually contained in individual compartments and used to differentiate and identify selected microorganisms. The device aids in the diagnosis of disease.

• Candida Albicans ID Antigen (FDA Code: LHK / 866.3165)

• Diagnostic Rapid Test Kits

• Influenza Virus Antisera (FDA Code: GNS / 866.3330)

Influenza virus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to influenza in serum. The identification aids in the diagnosis of influenza (flu) and provides epidemiological information on influenza. Influenza is an acute respiratory tract disease, which is often epidemic.

• Periodontal Probes

• Trichomonas Vaginalis Dna Probe (FDA Code: MJK / 866.2660)